Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

An improved method on isolation and serial passage of Chlamydia pneumoniae from human peripheral blood mononuclear cells.

Jin Q, Huang F, Sun S, Zhou Y, Xu X, Xi W.

J Clin Lab Anal. 2013 Nov;27(6):471-6. doi: 10.1002/jcla.21629.

PMID:
24218129
3.

[Production and application of Chlamydia pneumoniae-specific monoclonal antibody].

Wang W, Qian L, Shi Y, Li X, Bai Y, Xu J, Yu Z.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008 Jun;25(3):658-61. Chinese.

PMID:
18693451
4.

Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Roblin PM, Dumornay W, Hammerschlag MR.

J Clin Microbiol. 1992 Aug;30(8):1968-71.

5.

Evaluation of culture conditions used for isolation of Chlamydia pneumoniae.

Maass M, Harig U.

Am J Clin Pathol. 1995 Feb;103(2):141-8.

PMID:
7856555
6.

Is Chlamydia pneumoniae infection associated with stroke in children with sickle cell disease?

Goyal M, Miller ST, Hammerschlag MR, Gelling M, Gaydos CA, Hardick J, Wood BJ, Reznik T, Rao SP.

Pediatrics. 2004 Apr;113(4):e318-21.

PMID:
15060260
7.

Real-time PCR for Chlamydia pneumoniae utilizing the Roche Lightcycler and a 16S rRNA gene target.

Hardick J, Maldeis N, Theodore M, Wood BJ, Yang S, Lin S, Quinn T, Gaydos C.

J Mol Diagn. 2004 May;6(2):132-6.

8.

Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease.

Wong YK, Dawkins KD, Ward ME.

J Am Coll Cardiol. 1999 Nov 1;34(5):1435-9.

9.

Prevalence of viable Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors.

Yamaguchi H, Yamada M, Uruma T, Kanamori M, Goto H, Yamamoto Y, Kamiya S.

Transfusion. 2004 Jul;44(7):1072-8.

PMID:
15225250
10.

CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients.

Carralot JP, Dumrese C, Wessel R, Riessen R, Autenrieth I, Walter S, Schoor O, Stevanovic S, Rammensee HG, Pascolo S.

Int Immunol. 2005 May;17(5):591-7. Epub 2005 Mar 31.

PMID:
15802306
13.

Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells.

Mamata Y, Hakki A, Yamamoto Y, Newton C, Klein TW, Pross S, Friedman H.

Int Immunopharmacol. 2005 Apr;5(4):749-56.

PMID:
15710343
14.

Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Yamaguchi H, Oshio I, Osaki T, Kurata S, Yamamoto Y, Kamiya S.

Int J Exp Pathol. 2006 Apr;87(2):121-9.

16.

Presence of Chlamydia pneumoniae DNA in the artery wall--biomarker of coronary artery disease.

Kirbis J, Kese D, Petrovic D.

Folia Biol (Praha). 2005;51(5):145-7.

17.

Detection of Chlamydophila pneumoniae DNA in peripheral blood mononuclear cells of blood donors in the north-east of Italy.

Rassu M, Lauro FM, Cazzavillan S, Bonoldi E, Belloni M, Bettini MC, Pilotto A, Mengoli C, Peron A, Zambello R, Scagnelli M, Bertoloni G.

Med Microbiol Immunol. 2001 Dec;190(3):139-44.

PMID:
11827203
18.

Chlamydia pneumoniae, asthma, and COPD: what is the evidence?

Hahn DL.

Ann Allergy Asthma Immunol. 1999 Oct;83(4):271-88, 291; quiz 291-2. Review.

PMID:
10541419
19.

Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.

Wizel B, Starcher BC, Samten B, Chroneos Z, Barnes PF, Dzuris J, Higashimoto Y, Appella E, Sette A.

J Immunol. 2002 Sep 1;169(5):2524-35.

20.

Decontamination of a Mycoplasma-infected Chlamydia pneumoniae strain by pulmonary passage in SCID mice.

Essig A, Heinemann M, Schweitzer R, Simnacher U, Marre R.

Int J Med Microbiol. 2000 Jul;290(3):289-92.

PMID:
10959732

Supplemental Content

Support Center